Loading
Pharmanutra Pharmanutra S.p.a.: News and Updates on Foreign Markets Stock: price and insider trades · Italy
Pharmanutra Pharmanutra S.p.a.: News and Updates on Foreign Markets: what insiders have been doing
Pharmanutra Pharmanutra S.p.a.: News and Updates on Foreign Markets has a thin disclosure history in our data (latest filing: 2 April 2025). New filings will appear here as soon as they are published. Every figure here comes from the filings published by Consob and describes the past, not future prices; it is not investment advice.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 7,156 of 24,148 companies
61.8
score / 100
Value39
Quality85
FCF yld2.1%
Earn yld2.5%
EV/EBITDA23.8x
ROE30%
Gross mgn77%
Net mgn15%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
€83.00
Analyst consensus
3 analysts1.00/5
€76.00Target €81.33(-2%)€86.00
Income statement
Revenue€132.9M
Gross profit€102.9M77% margin
EBITDA€34.3M26% margin
Net income€20.0M15.1% margin
Valuation
PER (trailing)37.7x
PER (forward)27.1x
P/Book10.7x
Beta0.17
Balance sheet & cash
Market cap€794.7M
Total debt€20.5M
Free Cash Flow€16.4M
Debt / Equity26%
Profitability & ownership
ROE30.1%
ROA15.2%
% insiders65.0%
% institutions17.2%
Last declaration on 2 April 2025
About Pharmanutra Pharmanutra S.p.a.: News and Updates on Foreign Markets
Pharmanutra S.p.a. is an Italian company operating in the health and pharmaceutical sector. It focuses on the development and marketing of nutraceutical and pharmaceutical products.
